# OnCo record paper-palbociclib-breast-hr-positive-lancet-oncol-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-palbociclib-breast-hr-positive-lancet-oncol-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-palbociclib-breast-hr-positive-lancet-oncol-2015" ;
  schema:name "The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study"@en ;
  schema:description "Phase 2 or 3 results paper on Palbociclib in HR-positive / HER2-negative breast cancer, in The Lancet Oncology (2015), one of the most cited Europe PMC records with Palbociclib in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-palbociclib-breast-hr-positive-lancet-oncol-2015/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(14)71159-3>, <https://pubmed.ncbi.nlm.nih.gov/25524798/>, <https://europepmc.org/article/MED/25524798> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(14)71159-3> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Finn RS, Crown JP, Lang I, et al." ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .